Cozad Asset Management Inc Meridian Bioscience Inc Transaction History

Cozad Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$31.15 - $33.39 $253,249 - $271,460	8,130 New	8,130 $269,000
Q3 2021 Nov 05, 2021	SELL	$17.35 - $22.5 $186,686 - $242,100	-10,760 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$19.76 - $29.89 $6,520 - $9,863	-330 Reduced 2.98%	10,760 $282,000
Q3 2020 Oct 28, 2020	BUY	$13.54 - $26.41 $5,009 - $9,771	370 Added 3.45%	11,090 $188,000
Q2 2020 Aug 07, 2020	SELL	$7.84 - $23.29 $12,544 - $37,264	-1,600 Reduced 12.99%	10,720 $250,000
Q1 2020 May 07, 2020	BUY	$5.57 - $11.5 $68,622 - $141,680	12,320 New	12,320 $103,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Cozad Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cozad Asset Management Inc with notifications on news.